https://ameblo.jp/unitpharmacy/ ブログの説明を入力します。 ja Tofacent 5 mg (tofacitinib) is an advanced oral treatment for autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis. It works by inhibiting specific enzymes belonging to the Janus kinase (JAK) family. These kinases play a crucial role in the inflammatory processes underlying many autoimmune diseases. Developed by Incepta Pharmaceuticals Ltd. and marketed by Unit Pharmacy, it reduces joint pain, swelling, and stiffness by suppressing excessive immune system activity.
Tofacent 5 mg is primarily prescribed for the following conditions:
Rheumatoid arthritis: It provides significant improvement in symptoms in adults with moderate to severe rheumatoid arthritis (especially in patients who have not responded well to other treatments).
Psoriatic arthritis: This medication is also effective in managing psoriatic arthritis, addressing both joint and skin symptoms.

]]> https://ameblo.jp/unitpharmacy/entry-12974146445.html Wed, 29 Jul 2026 19:18:38 +0900